H.R. 3599, SECURE 340B Act, Issues related to drug pricing and patient access
Literal federal measure citations: H.R. 3599
2026 · 3rd Quarter (July 1 - Sep 30)
GENENTECH, INC.
Filed by YC CONSULTING, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 21, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- YC CONSULTING, LLC
- Client
- GENENTECH, INC.
- Filing UUID
- be8749dd-38d6-47c9-b569-86e915630f0f
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
H.R. 3269, ETHIC Act, Biopharmaceutical patent and intellectual property policy issues
Literal federal measure citations: H.R. 3269
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.